Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804362 · ClinicalTrials.gov registry record
Validation of the Sickle Cell Disease Pain Burden Interview
A clinical trial of Pain and Sickle Cell Disease, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- 131
- Enrollment target
- 1
- Study location
NCT00804362 is a study of Pain and Sickle Cell Disease that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 131 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00804362, a study of Pain and Sickle Cell Disease, has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- 131 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to validate a brief survey tool, the SCD Pain Burden Interview (SCPBI), which can be used in the clinical and/or research settings to assess the impact of pain on children with sickle cell disease.
Conditions Studied
Study Locations (1)
Connecticut
- Connecticut Children's Medical Center - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2008-12 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00804362
The ClinicalTrials.gov registry entry for NCT00804362 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (57% lower). The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 0 interventions.
NCT00804362 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00804362 about?
NCT00804362 is a clinical study titled "Validation of the Sickle Cell Disease Pain Burden Interview". The purpose of this study is to validate a brief survey tool, the SCD Pain Burden Interview (SCPBI), which can be used in the clinical and/or research settings to assess the impact of pain on children with sickle cell disease.
What is the current status of trial NCT00804362?
This trial is currently completed. The enrollment target is 131 participants. The study started on 2008-12. Estimated completion is 2012-12.
What conditions does trial NCT00804362 study?
This clinical trial studies the following conditions: Pain, Sickle Cell Disease.
Who is sponsoring clinical trial NCT00804362?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00804362 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
Pain With Dementia
RECRUITING · NA
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.